S 43 — Skinny Labels, Big Savings Act
Congress 119
Latest action: — Read twice and referred to the Committee on the Judiciary.
Sponsors
- Hickenlooper, John W. (D, CO-S) — sponsor · 2025-01-09
Lobbied by (2)
LDA filings that named this bill in their activity descriptions. The lobbying firm (registrant) is paid by the client to lobby on this and related issues.
| Filing | Period | Registrant (lobbying firm) | Client | Income | Matched |
|---|---|---|---|---|---|
| 1st Quarter - Report | 2026 first_quarter | MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90,000 | S. 43 |
| 1st Quarter - Report | 2026 first_quarter | FAEGRE DRINKER BIDDLE & REATH LLP | TEVA PHARMACEUTICALS USA, INC. | $60,000 | S 43 |
Action timeline
- — Read twice and referred to the Committee on the Judiciary.
- · 10000 — Introduced in Senate
Text versions
- Introduced in Senate · 2025-01-09 — open
Connected on the graph
Inbound (3)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | lobbies_on_bill | — | S. 43 | lobbying_bill_mention |
| 2026-01-01 | TEVA PHARMACEUTICALS USA, INC. | lobbies_on_bill | — | S 43 | lobbying_bill_mention |
| 2025-01-09 | Hickenlooper, John W. | sponsor_of_bill | — | sponsor | sponsorship |
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Hickenlooper, John W. (D, senate CO) | sponsor | 2 | — | 7 |
Who's influencing them
Orgs ranked by combined money flow on this bill: LDA filings citing the bill + individual contributions in cycle 2026from donors whose employer matches the org name (Schedule A) to any principal committee in the "who matters" list above.
| # | Org | LDA filings | LDA spend | Donor employees | Employee donations | Total |
|---|---|---|---|---|---|---|
| 1 | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | 1 | $90,000 | 0 | $0 | $90,000 |
| 2 | TEVA PHARMACEUTICALS USA, INC. | 1 | $60,000 | 0 | $0 | $60,000 |
| 3 | not employed | 0 | $0 | 258 | $26,789 | $26,789 |
| 4 | anthropic | 0 | $0 | 2 | $14,000 | $14,000 |
| 5 | goldbug | 0 | $0 | 1 | $7,000 | $7,000 |
| 6 | anthropic pbc | 0 | $0 | 1 | $7,000 | $7,000 |
| 7 | mit | 0 | $0 | 1 | $7,000 | $7,000 |
| 8 | self employed | 0 | $0 | 30 | $6,451 | $6,451 |
| 9 | freeport | 0 | $0 | 1 | $4,000 | $4,000 |
| 10 | unitleader | 0 | $0 | 1 | $3,300 | $3,300 |
| 11 | sutter hill ventures | 0 | $0 | 1 | $2,500 | $2,500 |
| 12 | steren electronics international, llc | 0 | $0 | 1 | $2,000 | $2,000 |
| 13 | invariant | 0 | $0 | 1 | $500 | $500 |
| 14 | resurgens orthopaedics | 0 | $0 | 1 | $500 | $500 |
| 15 | beckers healthcare and mcguirewoods | 0 | $0 | 1 | $500 | $500 |
| 16 | thoams z. hodson attorney at law | 0 | $0 | 1 | $350 | $350 |
| 17 | everest realty co | 0 | $0 | 1 | $250 | $250 |
| 18 | university of chicago law school | 0 | $0 | 1 | $250 | $250 |
| 19 | afb | 0 | $0 | 1 | $250 | $250 |
| 20 | liberty media | 0 | $0 | 1 | $250 | $250 |
| 21 | state of colorado | 0 | $0 | 1 | $125 | $125 |
| 22 | audubon | 0 | $0 | 1 | $100 | $100 |
| 23 | keramida inc | 0 | $0 | 1 | $100 | $100 |
| 24 | aeg | 0 | $0 | 1 | $100 | $100 |
| 25 | harris faberman | 0 | $0 | 1 | $100 | $100 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
1 predicted yes (0%) · 280 predicted no (52%) · 262 unknown (48%)
By party: · R: 0 yes / 277 no · D: 1 yes / 0 no / 262 unknown · I: 0 yes / 3 no
1 high-confidence positions (voted + sponsor + cosponsor)
- Hickenlooper, John W. (D · senate · CO) · sponsor
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-01-01 · lobbied on by THE CAMPAIGN FOR SUSTAINABLE RX PRICING (s. 43) · lobbying_bill_mention
- 2026-01-01 · lobbied on by TEVA PHARMACEUTICALS USA, INC. (s 43) · lobbying_bill_mention
- 2025-01-09 · sponsored by Hickenlooper, John W. (sponsor) · sponsorship